Patent classifications
A61K36/064
Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin
The present invention relates to compositions comprising probiotic and prebiotic components, mineral salts, lactoferrin, and possibly saccharomycetes, which perform correct, effective colonisation of the probiotic components administered, with enteric consequences which involve maintaining and/or restoring intestinal health and preventing the consequences of common dysbioses of the digestive tract caused by stress, incorrect dietary habits and antibiotic treatments. Said compositions also have a concomitant anti-inflammatory and immunomodulating action.
Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin
The present invention relates to compositions comprising probiotic and prebiotic components, mineral salts, lactoferrin, and possibly saccharomycetes, which perform correct, effective colonisation of the probiotic components administered, with enteric consequences which involve maintaining and/or restoring intestinal health and preventing the consequences of common dysbioses of the digestive tract caused by stress, incorrect dietary habits and antibiotic treatments. Said compositions also have a concomitant anti-inflammatory and immunomodulating action.
LACTOBACILLUS PARACASEI 207-27 AND USE THEREOF
The present application relates to a Lactobacillus paracasei or progeny thereof. Specifically, the present application relates to Lactobacillus paracasei 207-27 and a composition, culture, food product or dietary supplement containing the same. The present application also relates to the use of Lactobacillus paracasei 207-27 and the composition, culture, food product or dietary supplement containing the same in medicine.
LACTOBACILLUS PARACASEI 207-27 AND USE THEREOF
The present application relates to a Lactobacillus paracasei or progeny thereof. Specifically, the present application relates to Lactobacillus paracasei 207-27 and a composition, culture, food product or dietary supplement containing the same. The present application also relates to the use of Lactobacillus paracasei 207-27 and the composition, culture, food product or dietary supplement containing the same in medicine.
RED RICE FERMENT, PREPARATION METHOD THEREOF AND METHOD FOR IMPROVING SKIN CONDITION WITH THE SAME
A preparation method of a red rice ferment, including obtaining a red rice ferment by fermenting a red rice extract by yeast, Lactobacillus, and Acetobacter aceti. A red rice ferment is obtained from the preparation method of a red rice ferment. A method for improving skin condition of a subject in need thereof with the red rice ferment, comprising administering to the subject an effective dose of a composition containing the red rice ferment.
RED RICE FERMENT, PREPARATION METHOD THEREOF AND METHOD FOR IMPROVING SKIN CONDITION WITH THE SAME
A preparation method of a red rice ferment, including obtaining a red rice ferment by fermenting a red rice extract by yeast, Lactobacillus, and Acetobacter aceti. A red rice ferment is obtained from the preparation method of a red rice ferment. A method for improving skin condition of a subject in need thereof with the red rice ferment, comprising administering to the subject an effective dose of a composition containing the red rice ferment.
DELIVERY VEHICLE FOR IN SITU DELIVERING OF PHARMACEUTICAL AGENTS
The present invention relates to delivery vehicles comprising a system producing one or more active pharmaceutical ingredient (API) capable of preventing, treating and/or relieving one or more diseases in a mammal, wherein the vehicle comprises genetically modified microbial host cells suitable for administering to the mammal and wherein the vehicle is capable of delivering the produced API in situ of the location in the mammal body in need of preventing, treating and/or relieving the disease.
DELIVERY VEHICLE FOR IN SITU DELIVERING OF PHARMACEUTICAL AGENTS
The present invention relates to delivery vehicles comprising a system producing one or more active pharmaceutical ingredient (API) capable of preventing, treating and/or relieving one or more diseases in a mammal, wherein the vehicle comprises genetically modified microbial host cells suitable for administering to the mammal and wherein the vehicle is capable of delivering the produced API in situ of the location in the mammal body in need of preventing, treating and/or relieving the disease.
MUSCLE ENHANCER
A muscle enhancer containing a polyamine and a branched-chain amino acid as active ingredients. The polyamine may be one or more of putrescine, spermidine, and spermine, and may be derived from a yeast belonging to the genus Saccharomyces. The muscle enhancer may also comprise a crystalline polysaccharide. The muscle enhancer may be present in a food or a drink.
MUSCLE ENHANCER
A muscle enhancer containing a polyamine and a branched-chain amino acid as active ingredients. The polyamine may be one or more of putrescine, spermidine, and spermine, and may be derived from a yeast belonging to the genus Saccharomyces. The muscle enhancer may also comprise a crystalline polysaccharide. The muscle enhancer may be present in a food or a drink.